Nurofen See My Pain

1 in 6 women¹ experience severe pain every day, yet their pain is consistently overlooked in healthcare, underrepresented in research and dismissed due to ingrained gender biases. This leaves their pain misunderstood and mistreated.

Nurofen SEE MY PAIN is their commitment to make sure that all pain is seen, regardless of gender and help close the gender pain gap.

See The Facts

To fully understand the scale of the problem, Nurofen commissioned a Gender Pain Gap report.

• Women are in pain more often and more severely than men²
• 1 in 2 women (56%) feel they had their pain ignored or dismissed because of their gender.³

We hear you, we support you, we see your pain

Nurofen pledge to make a difference, to do all they can to help make women’s pain visible and provide tools to help you tackle bias and have constructive conversations with your healthcare provider.

Making women more visible in research and healthcare

• Nurofen is committed to gender balance in the design, conduct and analysis of clinical research and commit to including, studying and understanding women in research.
• Nurofen is investing in training to specifically support healthcare professionals identify and overcome and gender bias within their daily work.
• Nurofen commits to innovation that brings new and improved solutions for women’s pain.

Navigate your pain journey with confidence; get a free Pain Pass today

Keeping notes, or an account of your symptoms, can make the most out of your time at your appointment. This free tool is designed to help you tackle bias and have a constructive conversation with your healthcare professional.

Let’s get started…track your pain, record your symptoms and learn what to do when facing bias.

Download your personal pain pass

All information presented on these web pages is not meant to diagnose or prescribe. In all health matters for further information or medical advice, please speak to your doctor or pharmacist. Nurofen is the manufacturer of Nurofen 200mg Tablets. Contains ibuprofen. For short term, mild to moderate pain relief. Always read the label.

REFERENCES

1. GPG Index Survey References Document (26.08.2022 16.00GMT)
2. Hoffmann, Diane E. and Tarzian, Anita J., “The Girl Who Cried Pain: A Bias Against Women in the Treatment of Pain” (2001). Faculty Scholarship. 145.https://digitalscommons.law. umaryland.edu/fac_pubs/145
3. GPG Index Survey References Document (26.08.2022 16.00GMT)